Drug Level Monitoring for PrEP Users: Feasible and Acceptable, but Is It Necessary?
Background: Good adherence is vital for PrEP efficacy. Most adherence data come from clinical trials but real-world data for long-term PrEP use are lacking. Optimal support for PrEP adherence is not fully established and tenofovir (TFV) drug level monitoring (DLM) could identify those not taking PrEP. It is not known whether DLM would be acceptable…